Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine - PubMed (original) (raw)
. 2008 Jan 25;126(4):310-23.
doi: 10.1016/j.vetmic.2007.07.011. Epub 2007 Jul 17.
Affiliations
- PMID: 17719188
- DOI: 10.1016/j.vetmic.2007.07.011
Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine
Amy L Vincent et al. Vet Microbiol. 2008.
Abstract
Two US swine influenza virus (SIV) isolates, A/Swine/Iowa/15/1930 H1N1 (IA30) and A/Swine/Minnesota/00194/2003 H1N2 (MN03), were evaluated in an in vivo vaccination and challenge model. Inactivated vaccines were prepared from each isolate and used to immunize conventional pigs, followed by challenge with homologous or heterologous virus. Both inactivated vaccines provided complete protection against homologous challenge. However, the IA30 vaccine failed to protect against the heterologous MN03 challenge. Three of the nine pigs in this group had substantially greater percentages of lung lesions, suggesting the vaccine potentiated the pneumonia. In contrast, priming with live IA30 virus provided protection from nasal shedding and virus replication in the lung in MN03 challenged pigs. These data indicate that divergent viruses that did not cross-react serologically did not provide complete cross-protection when used in inactivated vaccines against heterologous challenge and may have enhanced disease. In addition, live virus infection conferred protection against heterologous challenge.
Similar articles
- Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA. Gauger PC, et al. Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23. Vaccine. 2011. PMID: 21310191 - Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
Reeth KV, Brown I, Essen S, Pensaert M. Reeth KV, et al. Virus Res. 2004 Jul;103(1-2):115-24. doi: 10.1016/j.virusres.2004.02.023. Virus Res. 2004. PMID: 15163499 - The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL. Kitikoon P, et al. Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28. doi: 10.1016/j.vetimm.2006.02.008. Epub 2006 Apr 18. Vet Immunol Immunopathol. 2006. PMID: 16621020 - Swine influenza virus vaccines: to change or not to change-that's the question.
Van Reeth K, Ma W. Van Reeth K, et al. Curr Top Microbiol Immunol. 2013;370:173-200. doi: 10.1007/82_2012_266. Curr Top Microbiol Immunol. 2013. PMID: 22976350 Review. - Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
Tamura S, Tanimoto T, Kurata T. Tamura S, et al. Jpn J Infect Dis. 2005 Aug;58(4):195-207. Jpn J Infect Dis. 2005. PMID: 16116250 Review.
Cited by
- A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
Borggren M, Nielsen J, Karlsson I, Dalgaard TS, Trebbien R, Williams JA, Fomsgaard A. Borggren M, et al. Vaccine. 2016 Jul 12;34(32):3634-40. doi: 10.1016/j.vaccine.2016.05.030. Epub 2016 May 19. Vaccine. 2016. PMID: 27211039 Free PMC article. - ISU FLUture: a veterinary diagnostic laboratory web-based platform to monitor the temporal genetic patterns of Influenza A virus in swine.
Zeller MA, Anderson TK, Walia RW, Vincent AL, Gauger PC. Zeller MA, et al. BMC Bioinformatics. 2018 Nov 1;19(1):397. doi: 10.1186/s12859-018-2408-7. BMC Bioinformatics. 2018. PMID: 30382842 Free PMC article. - Biomarkers associated with vaccine-associated enhanced respiratory disease following influenza A virus infection in swine.
Wymore Brand M, Souza CK, Gauger P, Arruda B, Vincent Baker AL. Wymore Brand M, et al. Vet Immunol Immunopathol. 2024 Jul;273:110787. doi: 10.1016/j.vetimm.2024.110787. Epub 2024 May 23. Vet Immunol Immunopathol. 2024. PMID: 38815504 - Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.
do Nascimento GM, de Oliveira PSB, Butt SL, Diel DG. do Nascimento GM, et al. Front Immunol. 2024 Feb 28;15:1322879. doi: 10.3389/fimmu.2024.1322879. eCollection 2024. Front Immunol. 2024. PMID: 38482020 Free PMC article. - An inactivated influenza D virus vaccine partially protects cattle from respiratory disease caused by homologous challenge.
Hause BM, Huntimer L, Falkenberg S, Henningson J, Lechtenberg K, Halbur T. Hause BM, et al. Vet Microbiol. 2017 Feb;199:47-53. doi: 10.1016/j.vetmic.2016.12.024. Epub 2016 Dec 21. Vet Microbiol. 2017. PMID: 28110784 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical